Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-07, with 11 holding rows worth $80,195,000.

Accession
0000950123-17-006742
Filed
2017-08-07
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2017

A holdings report, 11 entries on the cover page, a total value of $80,195,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $80,196,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Elevance Health, Inc.036752103COM55,200$10,385,000thousands by filing date
MCKESSON CORP COM58155Q103Stock63,100$10,382,000thousands by filing date
CENCORA INC COM03073E105Stock109,700$10,370,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM70,212$7,102,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW45,800$7,060,000thousands by filing date
Gilead Sciences,Inc.375558103COM97,600$6,908,000thousands by filing date
Pfizer Inc.717081103COM204,800$6,879,000thousands by filing date
LIGAND PHARMACEUTICALS INC53220K504COM NEW56,200$6,823,000thousands by filing date
BIOGEN INC COM09062X103Stock25,000$6,784,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM125,000$6,168,000thousands by filing date
IMMUCELL CORP452525306COM PAR182,133$1,335,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-17-006742this filing2017-08-07acceptance time not in the bulk data set